Several key events have emerged in relation to CVS Health Corporation (CVS). The company becomes the first in the U.S. to gain menopause-friendly accreditation, marking a significant milestone in its inclusivity efforts. A nurse practitioner reaches a settlement for refusing to provide contraceptives, showcasing CVS's commitment to employee rights. The stock performance of CVS has seen considerable activity, with numerous institutions like Thrivent Financial for Lutherans, Nomura Asset Management Co. Ltd., and Norges Bank increasing their positions in this biotech giant while others like Kiltearn Partners, LPL Financial, and Prudential Financial decreased their holdings. CVS's stock has been heavily searched by investors recently, indicating a heightening interest in the company’s performance. Consequently, hedge funds appear bullish on this oversold blue-chip stock. An unexpected event was CVS’s cancellation of the ACO REACH contract and the selling of its MSSP business to Wellvana. Despite recent losses, CVS Health has managed to maintain its dividend of $0.665, reassuring to existing and potential investors.
Cvs Health Corporation CVS News Analytics from Tue, 15 Oct 2024 07:00:00 GMT to Sat, 29 Mar 2025 22:14:52 GMT - Rating 2 - Innovation 5 - Information 8 - Rumor -5
